Home›Stock Screener›Vaxfab Enterprises›Financial Statements

Vaxfab Enterprises Complete Financial Statements

4 Years of Data
2025 - 2022

In FY2025, Vaxfab Enterprises (VEL) reported revenue ₹52 Cr, net profit ₹-2 Cr and EPS ₹-0.27, with a net profit margin of -3.8% and ROE of -11.8%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore VEL true value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -3.85% 2025 data
EBITDA Margin -5.77% 2025 data
Operating Margin 1.00% 2025 data
Return on Assets -7.41% 2025 data
Return on Equity -11.76% 2025 data

Balance Sheet Ratios

Equity Ratio 62.96% 2025 data
Asset Turnover 1.93 2025 data

VEL Revenue, Net Profit & EBITDA — Year-on-Year Growth

VEL YoY (Dec 2024 vs Sept 2025) — revenue +13.0%, net profit -133.3%, EBITDA -142.9%, expenses +38.5%. Review VEL earnings multiple to evaluate earnings-based valuation against sector peers.

Revenue Growth
+13.0%
Year-over-Year
Net Profit Growth
-133.3%
Year-over-Year
EBITDA Growth
-142.9%
Year-over-Year
Expense Growth
+38.5%
Year-over-Year
Assets Growth
+800.0%
Year-over-Year
Equity Growth
+466.7%
Year-over-Year

VEL Income Statement — Revenue, EBITDA & Net Profit

Vaxfab Enterprises revenue ₹52 Cr, EBITDA ₹-3 Cr, net profit ₹-2 Cr, EPS ₹-0.27 (2025) — net profit margin -3.8%. For live price, earnings ratios and company overview, see VEL stock price BSE.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Dec 2024 Mar 2023 Jun 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022
Revenue 52 52 12 12 46 14 4 0 0 0 2
Expenses 54 47 14 15 39 14 4 0 0 0 2
EBITDA -3 5 -1 -3 7 0 0 0 0 0 0
Operating Profit Margin % 1.00% 8.00% 7.00% 2.00% 14.00% 2.00% 6.00% -12.00% 33.00% 31.00% 7.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -3 5 -1 -3 6 0 0 0 0 0 0
Tax -1 1 0 0 0 0 0 0 0 0 0
Net Profit -2 4 -1 -3 6 0 0 0 0 0 0
Earnings Per Share (₹) -0.27 0.48 0.00 -0.39 0.76 0.33 0.31 0.01 0.88 0.02 0.85

VEL Balance Sheet — Assets, Liabilities & Shareholders' Equity

VEL total assets ₹27 Cr, total equity ₹17 Cr, total liabilities ₹ Cr (2023) — ROE -11.8%.

Years Annual Data ₹ Crores
Particulars 2023 2022
ASSETS
Total Assets 27 3
Current Assets 14 2
Fixed Assets 0 0
Capital Work in Progress 0 0
Investments 12 0
Other Assets 14 3
LIABILITIES
Total Liabilities
Current Liabilities 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 17 3
Share Capital 9 2
Reserves & Surplus 8 2

VEL Cash Flow Statement — Operating, Investing & Financing

Vaxfab Enterprises operating cash flow ₹2 Cr, investing ₹-12 Cr, financing ₹14 Cr, net cash flow ₹4 Cr (2023).

Periods ₹ Crores
Particulars March 2023 March 2022
Operating Activities 2 0
Investing Activities -12 0
Financing Activities 14 0
Net Cash Flow 4 0